Taiwan’s Vaccine Injury Compensation Program(VICP) approved it’s highest relief payment to date for a case of vaccine-induced thrombosis, October 21, according to minutes of the meeting released yesterday. The VICP reviewed 13 applications for compensation for adverse events following the AstraZeneca vaccine at the October 21 meeting. Among the cases, one involving a 30-year-old man from Taoyuan City who developed thrombosis in combination with thrombocytopenia syndrome (TTS), was determined to be related to the vaccine. The committee made their decision

The Central Epidemic Command Center announced four new cases of COVID-19 among people entering Taiwan from abroad, including three “breakthrough infections.” CDC Deputy Director-General Philip Lo (羅一鈞), who serves as Deputy Chief of the CECC’s medical response team said that there were no new domestically transmitted cases, nor deaths among confirmed cases, today, Tuesday, November 2. However, there were four new cases among arrivals from abroad, including three males and one female aged from their 40s to 60s. Two cases

Taiwan’s CDC announced a total of 8 new COVID-19 infections in the country October 25, of which six cases were among arrivals from abroad, all of whom were vaccinated. The six cases consisted of two men and four women who had arrived from the United Kingdom, the United States, and Indonesia, Deputy Leader of the Medical Response Team of the Central Epidemic Command Center (CECC), Philip Lo (羅一鈞), said. A British male in his 50s who arrived from the UK,

Taiwan’s Central Epidemic Command Center (CECC) today announced two new cases of COVID-19 imported from abroad, including one Taiwanese citizen who was fully vaccinated with three doses of the Pfizer-BioNTech vaccine while residing in the United States. CECC spokesman Chuang Jen-hsiang (莊人祥) said that the woman (case #16,458) is aged in her 20s and had the third dose of the BioNTech vaccine on September 10. The woman had a negative test report taken within three days of boarding her flight

Taiwan’s Centers for Disease Control (CDC) announced, October 13, that there were 117 new post-vaccination adverse events reported, including three deaths, of which the youngest was a 24-year-old man with no history of chronic disease. The CDC’s Central Epidemic Command Center (CECC) said that the 24-year-old Taichung City resident received the AstraZeneca shot on September 11, and developed symptoms of fever after returning home. The man took antipyretics (fever medication) and the fever symptoms subsided on September 13. On September

The New Taipei City Department of Health reported four cases of potentially vaccine-related fatal adverse events today, October 13, including the first following the Pfizer-BioNTech COVID-19 shot. The Health Department said that a 42-year-old man in Xinzhuang District developed chest tightness and cold sweats 9 days after being vaccinated with the BioNTech shot, October 1. The man was sent to the hospital for medical treatment, but died. The man did not suffer from high blood pressure, and only had a